Tarsus Pharmaceuticals, Inc.
TARS· Nasdaq
Released Aug 6, 2025, after the close
10-Q filed Aug 6, 2025, 37 days after period end · 0001819790-25-000108
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $102.66M | $40.81M | $0.00 | $15.28M |
| Net Income | -$20.34M | -$33.29M | -$31.42M | -$5.74M |
| EPS Diluted |
Tarsus Pharmaceuticals, Inc. · CIK 1819790 · Engraved from SEC EDGAR
| -$0.48 |
| -$0.88 |
| -$1.17 |
| -$0.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.